Citation Tools

Download PDFPDF
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps

Download to a citation manager

Cite this article as:
Rizk JG, Lewin JC
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps